Other languages CervoMed Inc.

Equities

CRVO

US15713L1098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
15.5 ^USD	-2.33%		-9.46%	+103.15%

Jul. 01	CervoMed Inc.(NasdaqCM:CRVO) added to Russell Small Cap Completeness Index	CI
Jul. 01	CervoMed Inc.(NasdaqCM:CRVO) added to Russell Microcap Growth Index	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies	Jun. 11
CervoMed Names William Elder CFO	May. 20
CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14
CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
CervoMed Prices $50 Million Equity Sale to Private Investors	Mar. 28
Cervomed Inc. Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal That Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies	Feb. 12
CervoMed Inc. Announces Appointment of Joshua Boger, Ph.D., to its Board of Directors and as Chair of the Board	Feb. 07
CervoMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
CervoMed Inc. Appoints Robert J. Cobuzzi as Director	Nov. 08
Cervomed Inc. Announces Resignation of Jill Davidson from the Board of Directors	23-10-31
Top Premarket Decliners	23-10-18
CervoMed Inc. Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy Bodies	23-10-18
CervoMed Inc. Announces Publication in Neurology® Results Showing A Blood Test At Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies	23-09-06
CervoMed Inc. Auditor Raises 'Going Concern' Doubt	23-07-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer